- Home
- Equipment
- usa california
- antigen presenting
Show results for
Refine by
Antigen Presenting Equipment Supplied In Usa California
15 equipment items found
Manufactured by:Khloris Biosciences, Inc. based inMountain View, CALIFORNIA (USA)
iPSC vaccination presents a differentiated approach to cancer treatment, targeting a panoply of antigens, leveraging the patient's immune system for optimized antigen presentation, and engaging both cellular and humoral ...
Manufactured by:T-Cure BioScience, Inc. based inSherman Oaks, CALIFORNIA (USA)
Our exclusive iSORT (Isolation of Optimal Reverse Immunology Generated TCR) platform is able to isolate TCRs against unique selected tumor-associated intracellular and extracellular antigens and neoantigens in the context of an HLA molecule, allowing us to focus on specific cancers and patient populations based on their genetic makeups. Using this technology, we are able to ...
by:Ionpath, Inc. based inMenlo Park, CALIFORNIA (USA)
Integrins mediate myeloid cell recruitment from the blood vessels into tissue and lymph nodes and contribute to the immunological synapse between T cells and antigen presenting ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The Antigen Rapid Test assay from the Gold Standard Diagnostics Group is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid (N) Protein antigens present in respiratory ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a single-use test kit intended to detect the presence of the SARS-CoV-2 virus, with self-collected nasal swab specimen from symptomatic individuals who are suspected of being infected with COVID-19. A positive result indicates SARS-CoV-2 antigens present in the ...
Manufactured by:Actym Therapeutics based inBerkeley, CALIFORNIA (USA)
In preclinical studies, STACT specifically enriches in many types of solid tumors and not in healthy tissue. Once there, STACT delivers multiplexed immuno-modulatory payloads directly to tumor-resident antigen-presenting cells. ...
Manufactured by:Fate Therapeutics, Inc. based inSan Diego, CALIFORNIA (USA)
Resistance to checkpoint inhibitor therapy has been linked to impaired immune cell infiltration into the tumor, impaired cytokine response, and deficiencies in antigen presentation including altered expression of major histocompatibility (MHC) class I complex. As a result, there is significant unmet need for novel therapeutic approaches to overcome resistance to ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
VAC2, which is produced from our pluripotent cell technology using a directed differentiation method, is comprised of a population of mature dendritic cells. As the most potent type of antigen presenting cell in the body, dendritic cells instruct our body’s immune system to attack and eliminate harmful pathogens and unwanted cells. To target cancerous ...
Manufactured by:Brooklyn ImmunoTherapeutics (BTX) based inSan Diego, CALIFORNIA (USA)
Why human derived? Brooklyn has developed a powerful method to create complex cytokine mixtures derived from a human source. Cytokines are powerful immune factors that play an essential role in T cell signaling, activation, proliferation, and tumor-fighting responses. We know cytokines may induce beneficial reactions in cancer patients. To date, available cytokine therapies have been recombinant ...
Manufactured by:IVD Research, Inc. based inCarlsbad, CALIFORNIA (USA)
Caused by the Campylobacter bacteria, campylobacteriosis is the most common human form of gastroenteritis in the world. Humans generally contract campylobacteriosis by consuming contaminated animal products. While the disease is generally not dangerous, it can be life-threatening for the elderly and young infants, as well as for people with compromised immune systems. It has also been associated ...
Manufactured by:Senti Biosciences based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio has established, and continues to scale, a powerful Design-Build-Test-Learn development engine to generate our therapeutic gene circuits. Unique to Senti Bio’s approach is the speed, quantity and quality of the multiple types of gene circuits designed, resulting in thousands of gene circuits engineered to date. Senti Bio believes that this approach to programming gene circuits is ...
Manufactured by:IVD Research, Inc. based inCarlsbad, CALIFORNIA (USA)
Giardiasis, caused by the single-celled Giardia lambliaparasite, is the most common parasitic disease in the United States. As many as 100 million mild infections and 1 million severe infections are reported ...
Manufactured by:Immune-Onc Therapeutics, Inc. based inPalo Alto, CALIFORNIA (USA)
Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid leukemia (AML) and chronic myelomonocytic leukemia ...
Manufactured by:Adicet Bio based inMenlo Park, CALIFORNIA (USA)
Gamma delta T cells represent a new generation of universal cell therapy. The current engineered autologous alpha beta T cell products have shown significant efficacy in hematological malignancies; however comparable efficacy in solid tumors is yet to be proven. The cell platform and novel targeting approaches Adicet is developing are aimed at harnessing the tumor specific immunity of gamma delta ...
Manufactured by:AIVITA Biomedical, Inc. based in, CALIFORNIA (USA)
AIVITA’s immunotherapy technology creates personalized vaccines for cancer patients that target and eliminate tumor-initiating cells which are the seed of the disease. Used alone or in parallel with other treatments, AIVITA’s cancer immunotherapy represents a powerful new approach in the search for curative treatments for ...